Close Menu

NEW YORK — Predictive Oncology on Wednesday announced that it has priced a public offering of approximately 6.3 million shares of common stock at $.50 per share for gross proceeds of up to roughly $3.2 million.

Dawson James Securities and Paulson Investment Company are acting as exclusive placement agents for the offering. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.